The SPRING Study: Severe acute resPiratory syndrome-Related coronavirus 2 prevalence In children and youNG adults in British Columbia
The objective of this study is to collect information from individuals who are under 25 years of age living in British Columbia, to help understand the rates of COVID-19 infection, even amongst those who may have had no symptoms. The researchers will combine the information they get from the survey, with that of similar studies across British Columbia, in order to help doctors better understand the spread of the virus and better understand how to safely allow people back to schools, day-cares, and other public places.
Overview
- Acronym
- SPRING
- Website
- SPRING
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 2020 -
- Recruitment Target
-
- Individuals
- Number of Participants
- 16,000
- Number of Participants with Biological Samples
- 16,000
- Supplementary information about number of participants
-
The final number is TBC - aiming for 2,500 in their first round and then up to 16,000, but that depends on the results from the first and subsequent batches and depends on seroprevalence estimates.
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
|
Timeline
Population
SPRING population
The population is composed of children and young adults under 25 years of age in British Columbia.
Selection Criteria
- Maximum age
-
24
- Countries
-
- Canada
- Canadian Provinces
-
- British Columbia
- Other Criteria
- Resident of British Columbia at the time of the study
Sources of Recruitment
- General Population
-
- Volunteer enrolment
- Supplementary Information
-
Participants were recruited online and are asked to fill in an inquiry form online or to contact the study by email.
Sample Size
- Number of Participants
- 16,000
- Number of Participants with Biological Samples
- 16,000
- Supplementary Information about selection criteria
-
The final number is TBC - aiming for 2,500 in their first round and then up to 16,000, but that depends on the results from the first and subsequent batches and depends on seroprevalence estimates.
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | SPRING - Survey |
|
2020 | Ongoing | |
| 1 | SPRING - Sample |
|
|
2020 | Ongoing |
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Datasets
| Name | Data Collection Events | Variables |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2024-02-27T16:01:09.131